Clearmind Medicine (CMND) Research & Development (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Research & Development of $646707.0 for Q2 2026, up 43.12% year-over-year from $451857.0 in Q2 2025, and up 0.97% quarter-over-quarter from $640494.0 in Q1 2026.
Clearmind Medicine (CMND) Research & Development (2022 - 2026) Analysis & Trends
Clearmind Medicine's Research & Development history runs 5 years deep, the most recent figure standing at $646707.0 for Q2 2026.
- In Q2 2026, Research & Development rose 43.12% year-over-year to $646707.0; the TTM figure through Apr 2026 stood at $2.4 million (up 39.23% YoY), while the FY2025 annual figure was $2.1 million, up 48.72% from the prior year.
- Research & Development for Q2 2026 stood at $646707.0, up from $640494.0 in the prior quarter.
- The five-year high for Research & Development was $1.3 million in Q4 2022, with the low at $12746.0 in Q1 2024.
- The 5-year median for Research & Development is $436019.5 (2025), against an average of $490791.1.
- The sharpest annual moves came in 2024 and 2025: Research & Development tumbled 97.83% in 2024, then surged 3520.26% in 2025.
- Clearmind Medicine's Research & Development stood at $1.3 million in 2022, then tumbled by 70.79% to $375073.0 in 2023, then advanced by 29.71% to $486491.0 in 2024, then retreated by 13.63% to $420182.0 in 2025, then soared by 53.91% to $646707.0 in 2026.
- Business Quant data shows CMND's Research & Development at $646707.0 in Q2 2026, $640494.0 in Q1 2026, and $420182.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 413.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 210.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 97.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -588.31 Mn |
| 10 | Clearmind Medicine | 520,887.91 | -13.07 Mn | - | 646,707.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 646,707.00 |
| Jan 31, 2026 | 640,494.00 |
| Oct 31, 2025 | 420,182.00 |
| Jul 31, 2025 | 723,048.00 |
| Apr 30, 2025 | 451,857.00 |
| Jan 31, 2025 | 461,438.00 |
| Oct 31, 2024 | 486,491.00 |
| Jul 31, 2024 | 345,883.00 |
| Apr 30, 2024 | 322,956.00 |
| Jan 31, 2024 | 12,746.00 |
| Oct 31, 2023 | 375,073.00 |
| Jul 31, 2023 | 263,954.00 |
| Apr 30, 2023 | 234,701.33 |
| Jan 31, 2023 | 587,630.00 |
| Oct 31, 2022 | 1.28 Mn |
| Jul 31, 2022 | 325,321.00 |
| Apr 30, 2022 | 916,482.44 |
| Jan 31, 2022 | 335,201.61 |